coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    North & Central Brighton PCN, Brighton and Hove (LAD) · Health Inequalities Profile

    PCN U55014 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,660

    Registered population

    82.3% aged 18–64

    9.1%

    Aged 65+

    ICB 21.9% · England 17.9%

    15.9%

    Ethnic minority (non-White)

    5.5% Asian · England 9.6%

    9.9%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~2,542

    Core20 residents (est.)

    Resident basis; registered basis ~3,273 · see page 3

    2,417

    Hypertension register

    +15.19% in 3 yrs · England +5.60%

    340

    SMI register

    7.3% of Brighton and Hove (LAD)'s

    339

    COPD register

    Reviews -9.38% in 3 yrs

    Forecast to 2030

    3,218

    Hypertension patients, 2030

    +801 on today

    73.4%

    QRISK ≥20% on statins, 2030

    +7.01pp over 3 yrs

    2.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    3,005
    Core20 and vaccination gaps concentrate at one practice.

    University Of Sussex Health Centre has 19.4% Core20 (3,005 estimated patients) and 28.9% vaccination; Montpelier Surgery 4.2% Core20; Seven Dials Medical Centre 88.5% vaccination.

    47.3%
    Screening, asthma reviews and lipid therapy lag England.

    Cervical screening in women aged 25-49 is 47.3% (England 66.8%), asthma reviews reach 55.5% (782 unreviewed), and QRISK ≥ 20% lipid therapy is 56.2%.

    84.6%
    SMI physical checks and hypertension control beat England.

    SMI blood pressure checks reach 84.6% (+14.1 pp over three years, England 83.4%), alongside 70.7% hypertension treatment to target and 60.2% non-frail diabetes HbA1c.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults form 82.3% of the list while older cohorts and children trail

    Across 36,660 registered patients, adults aged 18–64 represent 82.3% (30,167 patients), well above Brighton and Hove (71.4%), NHS Sussex Integrated Care Board (60.5%) and England (62.7%). Patients aged 65+ make up 9.1% (3,322 patients), below the borough (14.0%), ICB (21.9%) and England (17.9%), while children aged 0–17 comprise 8.7% (3,171). For local Census residents, White ethnicity is 84.1% (borough 85.4%, ICB 91.0%, England 81.1%), with an ethnic minority share of 15.9%, including Asian (5.5%) and Black (2.3%) residents. Age reflects registered patients, whereas ethnicity derives from resident Census data.

    Age profile

    0–178.7%
    18–6482.3%
    65+9.1%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White84.1%
    Asian5.5%
    Mixed5.1%
    Other3.0%
    Black2.3%

    Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Brighton and Hove LA)2,7022,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA)1,4859819552024/25
    Falls deaths, all ages, per 100,000 (Brighton and Hove LA)19.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 9.9% overall but spans a 19.4 pp practice range

    The PCN Core20 cohort is 9.9%, below England (21.0%) and Brighton and Hove (17.6%) but above NHS Sussex Integrated Care Board (9.2%). Deprivation is sharply uneven, spanning a 19.4 pp range: University Of Sussex Health Centre records 19.4% (3,005 estimated patients) and Montpelier Surgery records 4.2% (268 patients), while Carden Surgery and Seven Dials Medical Centre record 0.0%. Practice list estimates sum to 3,273 patients versus 2,542 resident decile 1+2 people. Proactive inequalities interventions should concentrate heavily on University Of Sussex Health Centre.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    University Of19.4% · 3,005 patients
    Montpelier4.2% · 268 patients
    Carden0.0% · 0 patients
    Seven Dials0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    340

    SMI register

    0.82% recorded prevalence

    117

    Learning disability register

    0.28% recorded prevalence

    10

    Care homes, 327 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Brighton and Hove (LAD), Census 2021

    Recorded severe mental illness prevalence is 0.8% (340 patients) and learning disability is 0.3% (117 patients), trailing Brighton and Hove (1.4% and 0.6%), NHS Sussex Integrated Care Board (1.1% and 0.6%) and England (1.0% and 0.6%). The catchment includes 10 care homes with 327 beds, though beds do not establish PCN registrations.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks (84.6%, England 83.4%) and BMI checks (83.9%, England 82.1%) exceed benchmarks, but University Of Sussex Health Centre trails at 73.7% and 68.4% respectively, indicating an outreach priority.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    2,417

    Hypertension register

    +15.19%

    Register growth, 3 yrs

    Brighton and Hove (LAD) +7.27% · England +5.60%

    +7.33pp

    BP control, under 80

    ≤140/90 · +6.52pp aged 80+

    +801

    More patients by 2030

    Forecast 3,218 (7.72%)

    Hypertension case-finding and control

    Hypertension register prevalence is 5.8% (2,417 patients; observation period not supplied), below Brighton and Hove (10.5%), NHS Sussex Integrated Care Board (16.3%), and England (15.2%), consistent with 82.3% of patients being aged 18-64. Blood pressure monitoring reaches 91.5% (England 90.0%), and treatment to target is 70.7% (England 70.3%). Among patients under 80, control is 68.9% (England 67.8%), though Carden Surgery records 60.3%. In patients aged 80 and over, control reaches 79.8% against 81.2% in England. While blood pressure monitoring and control exceed England across younger adults, lower control in patients aged 80 and over highlights a priority for targeted clinical reviews.

    Lipids and statins

    Lipid-lowering therapy reaches 56.2% for QRISK ≥ 20% (England 63.6%), 61.9% in CKD (England 70.3%), and 78.9% in diabetes with CVD (England 84.4%), where uptake fell 2.2% over three years (England +1.0%). Lower therapy rates than England across all three cohorts highlight scope for systematic clinical review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202625,415£2.20£2.42£1.86£55,913
    Cardiovascular (all), 202538,458£2.78£3.32£3.33£106,913

    For lipid-regulating drugs in 2026, 25,415 items were prescribed at £2.20 per item, below Brighton and Hove (£2.47) and NHS Sussex Integrated Care Board (£2.42), but £8,641 more than at England's unit cost (£1.86). Unit-cost differences illustrate indicator variance rather than prescribing efficiency or clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +16.77%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +11.90%

    Asthma prevalence, PCN 3-yr % change

    Asthma review coverage reached 55.5%, trailing England (65.7%) and Brighton and Hove (60.1%), leaving an estimated 782 of 1,758 register patients without a review despite a 3-year change of +16.8% (England +4.4%). Practice review rates range from 53.2% at Carden Surgery to 77.3% at Montpelier Surgery. Meanwhile, COPD review coverage fell 9.4% over three years (England +2.8%) to 71.1% (England 76.4%) across 339 patients. Review shortfalls across asthma and COPD suggest scope for systematic respiratory recall across member practices.

    Cancer register and children's immunisation

    The cancer register records 746 patients (1.8% prevalence vs England 3.8%), growing +16.4% over three years (England +9.0%). In childhood immunisations, 6-in-1 coverage at 12 months reaches 95.5%, meeting the 95.0% target. However, MMR dose 2 coverage at age 5 is 78.6% (England 82.8%), sitting 16.4 pp below the 95.0% target, with an 11.9 pp gap between first and second doses.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.5%

    England 91.0%

    6-in-1 complete primary course at 24 months92.3%

    England 92.2%

    MMR dose 1 at 24 months84.6%

    England 88.3%

    MMR dose 2 at age 578.6%

    England 82.8%

    4-in-1 pre-school booster at age 578.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    At ICB level in 2022, 58.5% of staged cancers in NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209), above England (55.3%) but 16.5 pp below the 75.0% national ambition, with known-stage coverage at 64.3% (8,209 of 12,766). ICB cervical cancer early-stage diagnosis was 58.2% (32 of 55), trailing England (67.6%). At PCN level, cervical screening uptake in women aged 25-49 is 47.3% (England 66.8%), with University Of Sussex Health Centre at 20.9%, contrasting with breast screening coverage at 70.4% (England 69.9%). Low working-age cervical screening uptake may be consistent with wider ICB cervical staging shortfalls, which clinical audit could test.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Provider waiting times describe the wider system rather than PCN performance. In July 2026, University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the cancer 62-day standard, trailing East Sussex Healthcare NHS Trust (67.0%), Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%) against the 85.0% standard. The trust reached 74.0% on the 28-day faster diagnosis standard and 76.8% on the 31-day combined treatment standard. Diagnostic 6-week-plus waits reached 39.3% for colonoscopy and 45.4% for flexi sigmoidoscopy. These acute delays reflect provider pressures outside direct PCN control.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityBrighton and Hove residentsSurrey and Sussex ICB
    Care contacts23,615309,615
    Referrals5,59066,930
    Patients with a contact7,35085,660

    Community services (residents of Brighton and Hove), Jun 2026 (provisional). In June 2026, community health service contacts for Brighton and Hove residents totalled 23,615, of which 14,325 contacts (60.7%) were with adults aged 65 and over. These provisional borough-level data reflect local authority resident contacts rather than PCN-level activity. High older-age community contacts reflect substantial local demand for complex care outside acute settings.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience varies by 24.4 pp, lowest at University Of Sussex Health Centre

    In 2025/26, QOF overall achievement ranged from 79.7% at University Of Sussex Health Centre to 91.5% at Montpelier Surgery (England 92.5%). Vaccination achievement showed a 59.5 pp spread, from 28.9% at University Of Sussex Health Centre to 88.5% at Seven Dials Medical Centre. University Of Sussex Health Centre recorded a 20.4% personalised care adjustment rate versus 10.0% nationally.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Carden Surgery1150.069.0%71.2%94.2%
    Seven Dials1010.076.0%76.5%91.9%
    Montpelier Surgery1004.287.1%76.6%90.7%
    University Of6119.466.8%66.2%69.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBrighton and Hove (LAD)AssetPCNBrighton and Hove (LAD)
    Care homes (catchment)10 (327 beds)n/aSchools (catchment)50n/a
    Children's centres314Places of worship45113
    Libraries413Homelessness support (VCS)0no data
    Primary schools (LA maintained)1435Primary academies17
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma review coverage is 55.5% (England 65.7%, Brighton and Hove 60.1%), leaving 782 of 1,758 register patients unreviewed. For discussion: practices could run structured asthma recall using a single clinical template, offering flexible remote or after-work review slots alongside inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pharmacist-led lipid therapy escalation review

    Lipid therapy trails England in QRISK ≥ 20% (56.2% vs 63.6%), CKD (61.9% vs 70.3%), and diabetes with CVD (78.9% vs 84.4%; 3-year change -2.2% vs England +1.0%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Targeted cervical screening and immunisation outreach

    Cervical screening (25–49 yrs) is 47.3% (England 66.8%; University Of Sussex Health Centre 20.9%), and QOF vaccination achievement spans 59.5 pp (28.9% to 88.5%). For discussion: practices could review recall wording, verify contact details, and offer flexible evening screening and vaccination clinics at University Of Sussex Health Centre. Moderate effort to run.

    Evidence base: the cancer register is the cohort for breast, bowel and cervical screening and for urgent suspected-cancer referral; where patients present as emergencies, the screening and referral steps have failed and symptom awareness needs support.

    Policy anchor: Core20PLUS5 — 75% of cancers diagnosed at stage 1 or 2 by 2028.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Working-age primary care access (p2)Aged 18-64Neighbourhood health frameworkPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Targeted SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older adult hypertension review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and survey review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Pharmacist-led lipid therapy escalation review (p12)Hypertension register · Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Targeted cervical screening and immunisation outreach (p12)Cancer register · Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · QOF vaccination and immunisation-domain achievementCore20PLUS5, 75% stage 1–2 by 2028PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15